Siren »

Benitec Biopharma shares owned by Siren

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Siren from 13F filings

Historical chart of Siren investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Siren

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 775k 13.47

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
BeOne Medicines Sponsored Ads (ONC)
Edgewise Therapeutics (EWTX)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Arrowhead Pharmaceuticals (ARWR)
Bicara Therapeutics (BCAX)
Olema Pharmaceuticals (OLMA)
Disc Medicine (IRON)
Structure Therapeutics Sponsored Ads (GPCR)
Tango Therapeutics (TNGX)
Arcus Biosciences Incorporated (RCUS)
Stoke Therapeutics (STOK)
Crinetics Pharmaceuticals In (CRNX)

View all positions for Siren

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
Nantahala Capital Management
BlackRock
Infinitum Asset Management
Siren
Alyeska Investment Group
Silverarc Capital Management
Geode Capital Management
AWM Investment Company
Schonfeld Strategic Advisors
State Street Corporation

View all funds holding Benitec Biopharma